Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Seattle Genetics Inc (NASDAQ:SGEN)

Delayed Data
As of Sep 22
 +0.12 / +0.23%
Today’s Change
Today|||52-Week Range
Institutional investors purchased a net $178.4 thousand shares of SGEN during the quarter ended June 2017 and now own 99.50% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Other institutional61.82%
Individual stakeholders41.92%
Mutual fund holders37.68%

Largest Quarterly Institutional

Latest Institutional Activity

6/30/2017CITADEL ADVISORS LLC  Bought 1.3 Million shares of Seattle Genetics Inc
6/30/2017HENDERSON GLOBAL INVESTORS LTD.  Bought 704.7 Thousand shares of Seattle Genetics Inc
6/30/2017CAPITAL RESEARCH & MANAGEMENT CO...  Bought 696.0 Thousand shares of Seattle Genetics Inc

Top 10 Owners of Seattle Genetics Inc

Total value ($)Shares
bought / sold
Baker Bros. Advisors LP31.97%45,725,5562,401,963,457+10,000+0.02%
Baillie Gifford & Co.11.07%15,839,321832,039,532-357,232-2.21%
PRIMECAP Management Co.9.06%12,958,975680,734,957-223,337-1.69%
Fidelity Management & Research Co...5.48%7,840,241411,847,860-2,312,056-22.77%
The Vanguard Group, Inc.5.27%7,530,515395,577,953+167,828+2.28%
BlackRock Fund Advisors4.18%5,971,478313,681,739+144,982+2.49%
T. Rowe Price Associates, Inc.2.69%3,845,518202,005,061+78,790+2.09%
SSgA Funds Management, Inc.1.96%2,809,762147,596,798-35,358-1.24%
Capital Research & Management Co....1.91%2,724,589143,122,660+695,986+34.31%
Matrix Capital Management Co. LP1.48%2,118,000111,258,540+335,000+18.79%

Top 10 Mutual Funds Holding Seattle Genetics Inc

Mutual fundStakeShares
Total value ($)Shares
bought / sold
PRIMECAP Odyssey Growth Fund3.86%5,522,700290,107,431-176,162-3.09%
PRIMECAP Odyssey Aggressive Growt...2.65%3,790,900199,135,977+8,000+0.21%
Fidelity Growth Company Fund1.59%2,275,836119,549,665-187,200-7.60%
Fidelity Select Biotechnology Por...1.52%2,173,190114,157,671-71,300-3.18%
American Funds New Perspective Fu...1.51%2,157,103113,312,621+2,157,103--
Vanguard Total Stock Market Index...1.50%2,150,055112,942,389+20,586+0.97%
iShares Nasdaq Biotechnology ETF1.37%1,963,460103,140,55400.00%
Vanguard Capital Opportunity Fund1.30%1,860,50097,732,06500.00%
T Rowe Price Mid Cap Value Fund1.04%1,490,33078,287,035+38,600+2.66%
Oppenheimer Global Opportunities ...0.98%1,400,00073,542,00000.00%